Evidence map›Paper›PMID 35243102›Full record

ArticleHeliyon2022

Anti-inflammatory, antioxidant, antihypertensive, and antiarrhythmic effect of indole-3-carbinol, a phytochemical derived from cruciferous vegetables.

Natalia Jorgelina Prado, Daniela Ramirez, Luciana Mazzei, Micaela Parra, Mariana Casarotto, Juan Pablo Calvo, Darío Cuello Carrión, Amira Zulma Ponce Zumino, Emiliano Raúl Diez, Alejandra Camargo and 1 more

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Natalia Jorgelina PradoInstitute of Experimental Medicine and Biology of Cuyo (IMBECU)-UNCuyo-CONICET, Mendoza 5500, Argentina.
Daniela RamirezInstituto de Biología Agrícola de Mendoza, (IBAM), Universidad Nacional de Cuyo, CONICET, Mendoza, Argentina.
Luciana MazzeiInstitute of Experimental Medicine and Biology of Cuyo (IMBECU)-UNCuyo-CONICET, Mendoza 5500, Argentina.
Micaela ParraFacultad de Ciencias Médicas, Universidad Nacional de Cuyo, Mendoza 5500, Argentina.
Mariana CasarottoFacultad de Ciencias Médicas, Universidad Nacional de Cuyo, Mendoza 5500, Argentina.
Juan Pablo CalvoFacultad de Ciencias Médicas, Universidad Nacional de Cuyo, Mendoza 5500, Argentina.
Darío Cuello CarriónInstitute of Experimental Medicine and Biology of Cuyo (IMBECU)-UNCuyo-CONICET, Mendoza 5500, Argentina.
Amira Zulma Ponce ZuminoFacultad de Ciencias Médicas, Universidad Nacional de Cuyo, Mendoza 5500, Argentina.
Emiliano Raúl DiezInstitute of Experimental Medicine and Biology of Cuyo (IMBECU)-UNCuyo-CONICET, Mendoza 5500, Argentina.
Alejandra CamargoInstituto de Biología Agrícola de Mendoza, (IBAM), Universidad Nacional de Cuyo, CONICET, Mendoza, Argentina.
Walter ManuchaInstitute of Experimental Medicine and Biology of Cuyo (IMBECU)-UNCuyo-CONICET, Mendoza 5500, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas · ARUniversidad Nacional de Cuyo · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiovascular inflammation and oxidative stress are determining factors in high blood pressure and arrhythmias. Indole-3-carbinol is a cruciferous-derived phytochemical with potential anti-inflammatory and antioxidant effects. However, its implications on the modulation of cardiovascular inflammatory-oxidative markers are unknown.

objectivesTo establish the effects of indole-3-carbinol on the oxidative-inflammatory-proarrhythmic conditions associated with hypertension. MATERIALS: Histological, biochemical, molecular, and functional aspects were evaluated in 1) Culture of mouse BV-2 glial cells subjected to oxidative-inflammatory damage by lipopolysaccharides (100 ng/mL) in the presence or absence of 40 μM indole-3-carbinol (n = 5); 2) Male spontaneously hypertensive rats (SHR) and Wistar Kyoto rats receiving indole-3-carbinol (2000 ppm/day, orally) during the first 8 weeks of life (n = 15); 3) Isolated rat hearts were submitted to 10 min regional ischemia and 10 min reperfusion.

results1) lipopolysaccharides induced oxidative stress and increased inflammatory markers; indole-3-carbinol reversed both conditions (interleukin 6, tumor necrosis factor α, the activity of nicotinamide adenine dinucleotide phosphate oxidase, nitric oxide, inducible nitric oxide synthase, heat shock protein 70, all p < 0.01 vs lipopolysaccharides). 2) SHR rats showed histological, structural, and functional changes with increasing systolic blood pressure (154 ± 8 mmHg vs. 122 ± 7 mmHg in Wistar Kyoto rats, p < 0.01); Inflammatory-oxidative markers also increased, and nitric oxide and heat shock protein 70 decreased. Conversely, indole-3-carbinol reduced oxidative-inflammatory markers and systolic blood pressure (133 ± 8 mmHg, p < 0.01 vs. SHR). 3) indole-3-carbinol reduced reperfusion arrhythmias from 8/10 in SHR to 0/10 (p = 0.0007 by Fisher's exact test).

conclusionsIndole-3-carbinol reduces the inflammatory-oxidative-proarrhythmic process of hypertension. The nitric oxide and heat shock protein 70 are relevant mechanisms of indole-3-carbinol protective actions. Further studies with this pleiotropic phytochemical as a promising cardioprotective are guaranteed.

Indexed as

ArrhythmiasHsp70HypertensionIndole-3-carbinolInflammationOxidative stress

Identifiers

PMID35243102
PMCPMC8866897
OpenAlexW4213388240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.